The Pharmabiotic Research Institute (PRI) draws together more than 30 stakholders from the probiotic and pharmaceutical industries. Its members believe that probiotics have the potential to prevent and even cure human disease - particularly human diseases that are known to be related to imbalances in the human microbiota (dysbiosis).